In controlled clinical studies involving 1,894 coating applications, there have been no serious adverse events attributed to Prevora. The rate of non-serious adverse events was 1.8 per 100 treatments. 94% of these events were in the oral cavity, almost all were considered "mild" and temporary, and consisted of: abnormal taste (45%), stinging of the oral mucosa (23%) and transient loss of taste (10%).
For a review of the contra-indications for Prevora, see the Product Monograph and for more details on Prevora's safety including the key toxicological features of chlorhexidine, download The Guide for the Dental Professional.
Approved by Health Canada - Drug Identification Number 02046245
